Couvreur P - Search Results

1

Intravitreal delivery of oligonucleotides by sterically stabilized liposomes.

Bochot A, Fattal E, Boutet V, Deverre JR, Jeanny JC, Chacun H, Couvreur P. Bochot A, et al. Among authors: couvreur p. Invest Ophthalmol Vis Sci. 2002 Jan;43(1):253-9. Invest Ophthalmol Vis Sci. 2002. PMID: 11773039

2

Liposomes dispersed within a thermosensitive gel: a new dosage form for ocular delivery of oligonucleotides.

Bochot A, Fattal E, Gulik A, Couarraze G, Couvreur P. Bochot A, et al. Among authors: couvreur p. Pharm Res. 1998 Sep;15(9):1364-9. doi: 10.1023/a:1011989202488. Pharm Res. 1998. PMID: 9755886

3

Intravitreal administration of antisense oligonucleotides: potential of liposomal delivery.

Bochot A, Couvreur P, Fattal E. Bochot A, et al. Among authors: couvreur p. Prog Retin Eye Res. 2000 Mar;19(2):131-47. doi: 10.1016/s1350-9462(99)00014-2. Prog Retin Eye Res. 2000. PMID: 10674705 Review.

4

Cationic emulsions improves the delivery of oligonucleotides to leukemic P388/ADR cells in ascite.

Teixeira H, Dubernet C, Chacun H, Rabinovich L, Boutet V, Deverre JR, Benita S, Couvreur P. Teixeira H, et al. Among authors: couvreur p. J Control Release. 2003 May 20;89(3):473-82. doi: 10.1016/s0168-3659(03)00101-9. J Control Release. 2003. PMID: 12737849

5

"Smart" delivery of antisense oligonucleotides by anionic pH-sensitive liposomes.

Fattal E, Couvreur P, Dubernet C. Fattal E, et al. Among authors: couvreur p. Adv Drug Deliv Rev. 2004 Apr 23;56(7):931-46. doi: 10.1016/j.addr.2003.10.037. Adv Drug Deliv Rev. 2004. PMID: 15066753 Review.

6

Biodegradable polyalkylcyanoacrylate nanoparticles for the delivery of oligonucleotides.

Fattal E, Vauthier C, Aynie I, Nakada Y, Lambert G, Malvy C, Couvreur P. Fattal E, et al. Among authors: couvreur p. J Control Release. 1998 Apr 30;53(1-3):137-43. doi: 10.1016/s0168-3659(97)00246-0. J Control Release. 1998. PMID: 9741921

7

Comparison of the ocular distribution of a model oligonucleotide after topical instillation in rabbits of conventional and new dosage forms.

Bochot A, Mashhour B, Puisieux F, Couvreur P, Fattal E. Bochot A, et al. Among authors: couvreur p. J Drug Target. 1998;6(4):309-13. doi: 10.3109/10611869808996838. J Drug Target. 1998. PMID: 9894698

8

Spongelike alginate nanoparticles as a new potential system for the delivery of antisense oligonucleotides.

Aynié I, Vauthier C, Chacun H, Fattal E, Couvreur P. Aynié I, et al. Among authors: couvreur p. Antisense Nucleic Acid Drug Dev. 1999 Jun;9(3):301-12. doi: 10.1089/oli.1.1999.9.301. Antisense Nucleic Acid Drug Dev. 1999. PMID: 10435755

9

Factors influencing the oligonucleotides release from O-W submicron cationic emulsions.

Teixeira H, Dubernet C, Rosilio V, Laigle A, Deverre JR, Scherman D, Benita S, Couvreur P. Teixeira H, et al. Among authors: couvreur p. J Control Release. 2001 Jan 29;70(1-2):243-55. doi: 10.1016/s0168-3659(00)00327-8. J Control Release. 2001. PMID: 11166424

10

Nanoparticulate systems for the delivery of antisense oligonucleotides.

Lambert G, Fattal E, Couvreur P. Lambert G, et al. Among authors: couvreur p. Adv Drug Deliv Rev. 2001 Mar 23;47(1):99-112. doi: 10.1016/s0169-409x(00)00116-2. Adv Drug Deliv Rev. 2001. PMID: 11251248 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

470 results

Search Page

Filters